Rational design of selective HDAC2 inhibitors for liver cancer treatment: computational insights into the selectivity mechanism through molecular dynamics simulations and QM/MM calculations

The comprehensive elucidation of the selectivity mechanism towards HDAC2 over HDAC8 would guide rational design of selective HDAC2 inhibitors for liver cancer treatment.